China has announced many deregulatory measures since unveiling an ambitious deregulatory agenda for its securities industry at the Conference on Innovation and Development of Securities Companies nearly a year ago...
In China, stricter regulation of banks' on-balance-sheet lending has paradoxically increased the overall economy's financial risk as banks have increasingly engaged in circumventive financing through use of off-balance-sheet products. ...
In 2012, the Chinese insurance industry experienced a slowdown in premium revenue growth and downturn in investment returns. Against such a backdrop, regulatory restrictions on their investment activities were eased...
Supported by the Chinese government, Hong Kong has been developing an offshore RMB market to promote the RMB's use outside of mainland China. Dim sum bonds, the first offshore RMB...
Reform is accelerating in China's securities sector. At an industry conference in May 2012, regulatory authorities unveiled plans to promote diversification of securities firms' operations through deregulation. They have recently...
In the first half of 2012, Chinese financial reform progressed faster than previously anticipated, with a proposed capital account liberalization timeline released in February, the renminbi's trading band widened in...
In 2011, Chinese securities investment funds performed poorly amid a decline in equity prices, revealing the fund industry's shortcomings in bold relief. In response, initiatives are afoot to diversify...
China has appointed new heads to its three core financial regulatory agencies (CBRC, CSRC, and CIRC) ahead of the next autumn's scheduled leadership transition. Chinese financial regulators are expected...
In China, the emergence of financial products designed to circumvent regulations is changing relationships between conventional monetary aggregates and economic activity. Chinese monetary authorities have started to develop new...
In 2010, China was the world's top-ranked commodity derivatives market by trading volume, although volume has since decreased drastically in response to a series of guidelines issued in November...